Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis off J Natl Kidney Found. 2014;63(5):713–35. https://doi.org/10.1053/j.ajkd.2014.01.416.
Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):e007525. https://doi.org/10.1136/bmjgh-2021-007525.
Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. https://doi.org/10.1016/j.kisu.2021.11.003.
Samaan F, Damiani BB, Kirsztajn GM, Sesso R. A cross-sectional study on the prevalence and risk stratification of chronic kidney disease in Cardiological patients in São Paulo, Brazil. Diagn Basel Switz. 2023;13(6):1146. https://doi.org/10.3390/diagnostics13061146.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. https://doi.org/10.1016/S0140-6736(12)61728-0.
Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15. https://doi.org/10.1007/978-981-13-8871-2_1.
Erfanpoor S, Etemad K, Kazempour S, Hadaegh F, Hasani J, Azizi F, et al. Diabetes, hypertension, and incidence of chronic kidney disease: is there any Multiplicative or Additive Interaction? Int J Endocrinol Metab. 2021;19(1):e101061. https://doi.org/10.5812/ijem.101061.
Tohidi M, Hasheminia M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS ONE. 2012;7(9):e45304. https://doi.org/10.1371/journal.pone.0045304.
Al-Rubeaan K, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM, et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS ONE. 2014;9(2):e88956. https://doi.org/10.1371/journal.pone.0088956.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.
Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79(4):365–79. https://doi.org/10.1007/s40265-019-1064-1.
Mayne KJ, Sullivan MK, Lees JS. Sex and gender differences in the management of chronic kidney disease and hypertension. J Hum Hypertens. 2023;37(8):649–53. https://doi.org/10.1038/s41371-023-00843-9.
Herrera-Añazco P, Benites-Zapata VA, León-Yurivilca I, Huarcaya-Cotaquispe R, Silveira-Chau M. Chronic kidney disease in Peru: a challenge for a country with an emerging economy. J Bras Nefrol. 2015;37(4):507–8. https://doi.org/10.5935/0101-2800.20150081.
Bravo-Zúñiga J, Gálvez-Inga J, Carrillo-Onofre P, Chávez-Gómez R, Castro-Monteverde P. Early detection of chronic renal disease: coordinated work between primary and specialized care in an ambulatory renal network of Peru. J Bras Nefrol. 2019;41(2):176–84. https://doi.org/10.1590/2175-8239-JBN-2018-0101.
Día. Mundial del Riñón: uno de cada diez adultos sufre de una enfermedad renal crónica. Available online: https://www.gob.pe/institucion/minsa/noticias/920304-dia-mundial-del-rinon-uno-de-cada-diez-adultos-sufre-de-una-enfermedad-renal-cronica (accessed on 23 March 2024).
Francis ER, Allen AK, Herrera-Añazco P, Kuo CC, Cardenas MK, Feldman HI, et al. Establishing a higher priority for chronic kidney disease in Peru. Lancet Glob Health. 2016;4(1):e17–18. https://doi.org/10.1016/S2214-109X(15)00206-5.
Francis ER, Kuo CC, Bernabe-Ortiz A, Nessel L, Gilman RH, Checkley W, et al. Burden of chronic kidney disease in resource-limited settings from Peru: a population-based study. BMC Nephrol. 2015;16:114. https://doi.org/10.1186/s12882-015-0104-7.
Carrillo-Larco RM, Miranda JJ, Gilman RH, Medina-Lezama J, Chirinos-Pacheco JA, Muñoz-Retamozo PV, et al. Risk score for first-screening of prevalent undiagnosed chronic kidney disease in Peru: the CRONICAS-CKD risk score. BMC Nephrol. 2017;18(1):343. https://doi.org/10.1186/s12882-017-0758-4.
Atamari-Anahui N, Ccorahua-Rios MS, Condori-Huaraka M, Huamanvilca-Yepez Y, Amaya E, Herrera-Añazco P. Epidemiology of chronic kidney disease in Peru and its relation to social determinants of health. Int Health. 2020;12(4):264–71. https://doi.org/10.1093/inthealth/ihz071.
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–304. https://doi.org/10.1001/jama.2019.14745.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
JBI Manual for Evidence Synthesis – JBI Global Wiki. Available online: https://jbi-global-wiki.refined.site/space/MANUAL (accessed on 24 October 2023).
Meneses Liendo V, León Rabanal C, Huapaya Carrera J, Cieza Zevallos J. Sobrevida en hemodiálisis según El Periodo De ingreso de pacientes entre 1982 y 2007 en Lima, Perú. Rev Med Hered. 2011;22(4):157–8.
Herrera-Añazco P, Benítes-Zapata VA, Hernandez AV. Factores asociados a mortalidad intrahospitalaria de una población en hemodiálisis en el Perú. Rev Peru Med Exp Salud Pública. 2015;479 – 84. https://doi.org/10.17843/rpmesp.2015.323.1677.
Herrera-Añazco P, Benites-Zapata V, Hernandez AV, Mezones-Holguin E, Silveira-Chau M. Mortalidade Dos pacientes com doença renal crônica em hemodiálise de manutenção em um hospital público do Peru. Braz J Nephrol. 2015;37:192–7. https://doi.org/10.5935/0101-2800.20150031.
Huamán CL, Postigo OC, Contreras CC. Características epidemiológicas De Los pacientes que inician hemodiálisis crónica en El Hospital Alberto Sabogal Sologuren 2015. Horiz Méd Lima. 2016;16(2):6–12.
Bravo-Zúñiga J, Chávez-Gómez R, Gálvez-Inga J, Villavicencio-Carranza M, Espejo-Sotelo J, Riveros-Aguilar M. [Progression of chronic renal disease in a reference hospital of social security of Peru 2012–2015]. Rev Peru Med Exp Salud Publica. 2017;34(2):209–17. https://doi.org/10.17843/rpmesp.2017.342.2493.
Gómez de la Torre-, del Carpio A, Bocanegra-Jesús A, Guinetti-Ortiz K, Mayta-Tristán P, Valdivia-Vega R. Mortalidad precoz en pacientes con enfermedad renal crónica que inician hemodiálisis por urgencia en una población peruana: Incidencia Y factores de riesgo. Nefrología. 2018;38(4):425–32. https://doi.org/10.1016/j.nefro.2017.11.017.
Herrera-Añazco P, Taype-Rondan A, Lazo-Porras M, Alberto Quintanilla E, Ortiz-Soriano VM, Hernandez AV. Prevalence of chronic kidney disease in Peruvian primary care setting. BMC Nephrol. 2017;18(1):246. https://doi.org/10.1186/s12882-017-0655-x.
Pinares-Astete F, Meneses-Liendo V, Bonilla-Palacios J, Ángeles-Tacchino P, Cieza-Zevallos J. Supervivencia a largo plazo en pacientes con enfermedad renal crónica estadio 5 tratada por hemodiálisis en Lima, Perú. Acta Médica Peru. 2018;35(1):20–7.
Huauya-Leuyacc C, Palacios-Guillen AM, Benites-Zapata VA. Factores epidemiológicos asociados a la referencia temprana al nefrólogo para hemodiálisis crónica en pacientes de Un Hospital Público De Perú. Rev Nefrol Diál Traspl. 2018;126 – 33.
Herrera-Añazco P, Taype-Rondan A, Ortiz PJ, Málaga G, Del Carpio-Toia AM, Alvarez-Valdivia MG, et al. Use of medicinal plants in patients with chronic kidney disease from Peru. Complement Ther Med. 2019;47:102215. https://doi.org/10.1016/j.ctim.2019.102215.
Loaiza-Huallpa J, Condori-Huaraka M, Quispe-Rodríguez GH, Pinares-Valderrama MP, Cruz-Huanca AI, Atamari-Anahui N, et al. Mortalidad Y factores asociados en pacientes con enfermedad renal crónica en hemodiálisis en un hospital peruano. Rev Habanera Cienc Médicas. 2019;18(1):164–75.
Bravo-Zúñiga J, Saldarriaga EM, Chávez-Gómez R, Gálvez-Inga J, Valdivia-Vega R, Villavicencio-Carranza M, et al. Effectiveness of adherence to a renal health program in a health network in Peru. Rev Saude Publica. 2020;54:80. https://doi.org/10.11606/s1518-8787.2020054002109.
Pineda-Borja V, Andrade-Santiváñez C, Arce-Gomez G, Rabanal CL. Peritonitis en pacientes que reciben diálisis peritoneal en un hospital de Lima, Perú. Rev Peru Med Exp Salud Pública. 2020;521–6. https://doi.org/10.17843/rpmesp.2020.373.4744.
Munive-Yachachi Y, Delgado-Pérez D, Munive-Yachachi Y, Delgado-Pérez D. Prevalencia De desnutrición en pacientes con enfermedad renal crónica terminal en un hospital nacional de Lima, Perú. Fac Med. 2021;82(1):21–6. https://doi.org/10.15381/anales.v82i1.18037.
Valenzuela-Narváez RV, Valenzuela-Narváez DR, Valenzuela-Narváez DAO, Córdova-Noel ME, Mejía-Ruiz CL, Salcedo-Rodríguez MN, et al. Periodontal disease as a predictor of chronic kidney disease (CKD) stage in older adults. J Int Med Res. 2021;49(7):3000605211033266. https://doi.org/10.1177/03000605211033266.
Umeres-Francia GE, Rojas-Fernández MV, Herrera-Añazco P, Benites-Zapata VA. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease. Ren Replace Ther. 2022;8(1):30. https://doi.org/10.1186/s41100-022-00420-9.
Guzman-Ventura W, Caballero-Alvarado J. Survival of patients on chronic hemodialysis versus chronic peritoneal dialysis. Rev Peru Med Exp Salud Publica. 2022;39(2):161–9. https://doi.org/10.17843/rpmesp.2022.392.10853.
Bravo LJA, Gonzales RFL, Izarra ME, Rada APVY, Cairampoma DEM. Características epidemiológicas, de laboratorio y de tratamiento en pacientes con hemodiálisis en una población de altura. Rev Peru Cienc Salud. 2022;4(2):92–7. https://doi.org/10.37711/rpcs.2022.4.2.370.
Venegas Justiniano JY, Hurtado Aréstegui A, Loza Muñarriz C, Venegas Justiniano JY, Hurtado Aréstegui A, Loza Muñarriz C. Características de la colocación y permanencia de catéteres venosos centrales temporales para hemodiálisis en un hospital público 2015–2019. Acta Médica Peru. 2022;39(2):128–37. https://doi.org/10.35663/amp.2022.392.2231.
Herrera-Añazco P, Segura MA, Bravo-Zúñiga J, Vásquez JL, Taype-Rondán A. Hospitalization and mortality during the pandemic in chronic hemodialysis patients and the general population in Peru. J Bras Nefrol. 2023;S:0101–28002023005018501. https://doi.org/10.1590/2175-8239-JBN-2022-0149en.
Huaman-Carhuas L, Melo-Flores CM, Gutiérrez-Carranza MD, Huaman-Carhuas L, Melo-Flores CM, Gutiérrez-Carranza MD. Calidad Percibida Y Su relación con la satisfacción del paciente en tratamiento con hemodiálisis en un hospital público de Perú. Enferm Nefrológica. 2023;26(2):159–66. https://doi.org/10.37551/s2254-28842023016.
Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662–4. https://doi.org/10.1016/S0140-6736(19)32977-0.
CDC Surveillance System. CKD Among U.S. Adults, by Stage. Available online: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q372 (accessed on 2 September 2023).
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease – A systematic review and Meta-analysis. PLoS ONE. 2016;11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765.
Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96(5):1048–50. https://doi.org/10.1016/j.kint.2019.07.012.
CDC Surveillance System: CKD Among U.S. Adults. Available online: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q9&topic=1#refreshPosition (accessed on 2 September 2023).
Sundström J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study. Lancet Reg Health – Eur. 2022. https://doi.org/10.1016/j.lanepe.2022.100438.
Suriyong P, Ruengorn C, Shayakul C, Anantachoti P, Kanjanarat P. Prevalence of chronic kidney disease stages 3–5 in low- and middle-income countries in Asia: a systematic review and meta-analysis. PLoS ONE. 2022;17(2):e0264393. https://doi.org/10.1371/journal.pone.0264393.
Shrestha N, Gautam S, Mishra SR, Virani SS, Dhungana RR. Burden of chronic kidney disease in the general population and high-risk groups in South Asia: a systematic review and meta-analysis. PLoS ONE. 2021;16(10):e0258494. https://doi.org/10.1371/journal.pone.0258494.
CDC Surveillance System: CKD Among U.S. Adults. Available online: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q9&topic=1&Strat=Hypertension#refreshPosition (accessed on 2 September 2023).
Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL, et al. The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey. PLoS ONE. 2015;10(4):e0124506. https://doi.org/10.1371/journal.pone.0124506.
Ameer OZ. Hypertension in chronic kidney disease: what lies behind the scene. Front Pharmacol. 2022;13:949260. https://doi.org/10.3389/fphar.2022.949260.
CDC Surveillance System: CKD Among U.S. Adults. Available online: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q9&topic=1&Strat=Diabetes#refreshPosition (accessed on 2 September 2023).
CDC Surveillance System. CKD Stages 3–4, by Diabetes and Prediabetes. Available online: https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q702 (accessed on 2 September 2023).
Fernández-Fernández L, Barquilla-García A, Sánchez-Vega J, Risco-Solanilla JC, Suárez-González F, Buitrago F. Prevalence of chronic kidney disease in patients with diabetes in Extremadura (Spain) during the Years 2012, 2013 and 2014: an observational study. J Clin Med. 2021;10(13):2886. https://doi.org/10.3390/jcm10132886.
Gatwood J, Chisholm-Burns M, Davis R, Thomas F, Potukuchi P, Hung A, et al. Evidence of chronic kidney disease in veterans with incident diabetes mellitus. PLoS ONE. 2018;13(2):e0192712. https://doi.org/10.1371/journal.pone.0192712.
Pecoits-Filho R, Abensur H, Betônico CCR, Machado AD, Parente EB, Queiroz M, et al. Interactions between kidney disease and diabetes: dangerous liaisons. Diabetol Metab Syndr. 2016;8(1):50. https://doi.org/10.1186/s13098-016-0159-z.
- The Renal Warrior Project. Join Now
- Source: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03595-x